4th Jul 2016 15:36
|
| |||||
|
| |||||
| ||||||
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | ||||||
|
| |||||
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii | OptiBiotix Health Plc
| |||||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||||
An acquisition or disposal of voting rights | ü | |||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
| |||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
| |||||
An event changing the breakdown of voting rights |
| |||||
Other (please specify): |
|
| ||||
3. Full name of person(s) subject to thenotification obligation: iii |
| |||||
4. Full name of shareholder(s) (if different from 3.):iv |
| |||||
5. Date of the transaction and date onwhich the threshold is crossed orreached: v | 24 June 2016 | |||||
6. Date on which issuer notified: | 29 June 2016 | |||||
7. Threshold(s) that is/are crossed orreached: vi, vii | 16% | |||||
8. Notified details: | ||||||||||||||||
A: Voting rights attached to shares viii, ix | ||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | ||||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | ||||||||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||
GB00BP0RTP38 | 12,598,238 | 12,598,238 | 11,999,314 | 11,999,314 | nil | 15.40 | Nil | |||||||||
| ||||||||||||||||
| ||||||||||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financialinstrument | Expirationdate xiii | Exercise/Conversion Period xiv | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | ||||||||||||
None |
|
|
|
| ||||||||||||
| ||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financialinstrument | Exercise price | Expiration date xvii | Exercise/Conversion period xviii | Number of voting rights instrument refers to
| % of voting rights xix, xx
| |||||||||||
None |
|
|
|
| Nominal | Delta | ||||||||||
|
| |||||||||||||||
| ||||||||||||||||
Total (A+B+C) | ||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||
11,999,314 | 15.40% | |||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi | ||
| ||
| ||
Proxy Voting: | ||
10. Name of the proxy holder: |
| |
11. Number of voting rights proxy holder will ceaseto hold: |
| |
12. Date on which proxy holder will cease to holdvoting rights: |
| |
| ||
13. Additional information: |
| |
14. Contact name: | Enterprise Ventures Limited | |
15. Contact telephone number: | 01772 270 570 | |
Related Shares:
OptiBiotix Health